We’d like you to agree to a 20-minute interview. We will pay an honorarium if we are allowed to under the prevailing regulations.
We are working in partnership with the International Longevity Centre (ILC) and a global pharmaceutical company, and are keen to understand the perception from experts of
- The use of a monovalent aP booster versus Tdap in pregnancy and other settings
- Whether there is any unprompted awareness of the number of pertussis components in vaccines used for primary immunisation or as boosters
- What spontaneous or prompted awareness there is about discussions on the use of Ap versus wP in primary immunisation
We appreciate your willingness to speak with us under market research rules. Those rules mean that we will report your answers and those of other interviewees, so no one can identify who said what. In this project, we will not tell the client the names of those we have interviewed, but will give a general idea of the responsibilities and experience of those who answered our questions.
This project is being conducted under the supervision of Mark Chataway, a member of ESOMAR, the international professional body for market and policy researchers.
Questions around the above topics will be related to Bionet.
Please complete the following form for us to arrange the interview in the coming weeks
